LatestIP And Trademarks 22 October 2026
Godavari Biorefineries Wins US Patent for Anti‑Cancer Drug
Godavari Biorefineries secured a US patent for its anti‑cancer compound, following approvals in India, China and Japan. The new patent bolsters its global IP portfolio and may speed up commercial development of the therapy.
Godavari Biorefineries has secured a US patent for its anti‑cancer compound, joining earlier approvals in India, China and Japan. See the full announcement here.
- Patent expands global IP coverage.
- Could accelerate commercial rollout of the therapy.
- Strengthens the company’s position in the biotech market.
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.